drugset / Trial / NCT05272254

Povidone Iodine Efficacy Study

NCT05272254

Phase 2 Recruiting 202 enrolled University of Rochester
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This is a single center, randomized, double-blind, placebo-controlled Phase II clinical trial (RCT) to evaluate the efficacy of topical 10% Polyvinylpyrrolidone-Iodine (PVPI) to prevent new caries lesions when applied to the teeth of children with Severe Early Childhood Caries (S-ECC). At baseline, following oral rehabilitation in the operating room {10% (PVPI + Fluoride Varnish (FV)} will be compared to the current standard of care (Placebo + FV). Study participants will be followed for approximately 24 months post-baseline. The study interventions post-baseline will be administered at 3, 6, 9, 12, 15, 18, and 21 months.

Timeline

Start
2022-09-15
Primary completion
2027-05
Completion
2027-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Povidone-Iodine Other / unclassified 10 % Topical
Background sodium fluoride Unknown 5 % Topical

Indications